Last updated: 2026-09-16 07:34:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Agilent Technologies Inc. (A) operates in the LABORATORY ANALYTICAL INSTRUMENTS sector and is listed on NYSE. The stock is currently priced at $150.25, with a market capitalisation of $41.39B and a P/E ratio of 29.42. Over the past 52 weeks, its price has ranged from $108.35 to $163.75. This page covers its latest market performance, valuation, price trends and company information.
$41.39B | |
$147.00 | |
$179.57 | |
$8.60 | |
$146.80 | |
1.21M | |
2.19M | |
29.42 | |
$163.75 | |
$108.35 | |
0.68% | |
-- |
Agilent Technologies Inc. (A) last closed at $146.80 as of 2026-09-15 23:35:00, unchanged from the previous close of $146.80.
During the latest regular trading session, A traded between $8.60 and $179.57, with a volume of 1.21M shares. The closing price was near the upper end and near the upper end of its 52-week range.
Over the past seven days, Agilent Technologies Inc. (A) moved from $150.86 to $150.25, representing a decline of 0.40% ($0.61).
The stock traded between $141.25 and $151.59 during the period. The latest price is near the upper end of the 7-day range, indicating range-bound.
The average daily volume was 1.70 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 75.6%
A is currently trading at $150.25, placing it 75.6% of the way from its 52-week low of $108.35 to its 52-week high of $163.75. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
| Industry | LABORATORY ANALYTICAL INSTRUMENTS |
| Employees | 18200 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Agilent Technologies Inc. (A) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.